信达生物 · INNOVENT BIOLOGICS, INC.
Ownership & governance
Executives 5Directors 8Avg age 62Avg tenure 7.5y
DY
De Chao Yu
Chief Executive Officer
Age 62Since 2011-04-27Profile →
+12
Executives5
Board of directors8
DY
De Chao Yu→
Chairman
Age 62Since 2011-04-27
CC
Charles Cooney→
Director/Board Member
Age 81Since 2015-10-17
HE
Hao Xi Ede→
Director/Board Member
Age 67Since 2018-06-03
IH
I Yin Hsu→
Director/Board Member
Age 52Since 2018-10-17
GZ
Gary Zieziula→
Director/Board Member
Age 71Since 2022-05-30
SC
Shu Yun Chen→
Director/Board Member
Age 51Since 2018-01-30
QZ
Qian Zhang→
Director/Board Member
Age 39Since 2024-05-02
SS
Stephen Sherwin→
Director/Board Member
Age 77Since 2025-08-25
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| De Chao Yu | 6.332 % | 110,058,657 |
| Temasek Holdings Pte Ltd. (Investment Management) | 4.091 % | 71,106,537 |
| LAV Management Co., Ltd. | 2.939 % | 51,083,040 |
| BlackRock Fund Advisors | 2.826 % | 49,123,160 |
| ICBC UBS Asset Management Co. Ltd. | 1.419 % | 24,661,838 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| De Chao Yu | Chief Executive Officer | 2011-04-27 | - |
| De Chao Yu | Chairman | 2011-04-27 | - |
| Fei You | Director of Finance/CFO | 2024-02-04 | - |
| Ghang Shou Gao | Chief Tech/Sci/R&D Officer | 2020-10-31 | - |
| Hao Xi Ede | Director of Finance/CFO | 2018-06-03 | - |
| Qin Wei Zhou | Chief Operating Officer | 2016-06-15 | - |
| Charles Cooney | Director/Board Member | 2015-10-17 | - |
| Gary Zieziula | Director/Board Member | 2022-05-30 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 129.7Range 94.61–156.58Analysts 29
94.61Mean 129.7156.58
- Strong buy 7
- Buy 21
- Hold 2
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.